Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA crosslinks are covalent bonds formed between two nucleotides within the same strand (intrastrand) or across opposite strands (interstrand) of double-stranded DNA. These lesions can be caused by exogenous agents such as chemotherapeutic drugs (e.g., cisplatin, melphalan, mitomycin C), environmental toxins, or endogenous metabolic products. Crosslinks block essential cellular processes like replication and transcription; if unrepaired, they trigger cell death through apoptosis. This property is exploited in cancer chemotherapy to selectively kill rapidly dividing tumor cells. However, the process itself is not a discrete molecular target such as a receptor or enzyme but rather a type of chemical damage induced in the genome[2][4]. Therefore, "DNA crosslinking causing apoptosis" describes a mechanism or effect rather than an individual molecular entity that can be directly targeted by drugs. **Note:** There is something incorrect with this entry as it refers to a process/mechanism ("DNA crosslinking causing apoptosis") rather than an individual molecule/receptor/target protein. The canonical form should refer to specific enzymes involved in repair pathways or specific drug targets that induce this effect—not the process itself[2][4].
Induction of apoptosis via inhibition of DNA replication and transcription by covalent linkage between nucleotides[2][4]
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA crosslink.